Top

Reactions Weekly

Published in:

01-04-2024 | Cabergoline | Case report

Cabergoline

Lack of efficacy and drug exposure during pregnancy with delivery of healthy neonate

Published in: Reactions Weekly | Issue 1/2024

Excerpt

Author Information

An event is serious (based on the ICH definition) when the patient outcome is:

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* other medically important event

…

Zainal A, et al. A Challenging Case of Pituitary Macroprolactinoma During Pregnancy. Journal of the Endocrine Society 5 (Suppl. 1): A564-A565, May 2021. Available from: URL: https://dx.doi.org/10.1210/jendso/bvab048.1150 [abstract]

Title: Cabergoline
Lack of efficacy and drug exposure during pregnancy with delivery of healthy neonate
Publication date: 01-04-2024
Publisher: Springer International Publishing
Keywords: Cabergoline
Prolactinoma
Published in: Reactions Weekly / Issue 1/2024
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-024-56739-4

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Cabergoline

Lack of efficacy and drug exposure during pregnancy with delivery of healthy neonate

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2024

Cyclophosphamide

Furosemide/Propranolol/Spironolactone

Leuprorelin

Tacrolimus

Carbamazepine/levofloxacin

Diazoxide/Glucose/Prednisone